Metabolic Syndrome increases the Risk of Primary Liver Cancer (HCC, CCC) in the United States: A Population-Based Case-Control Study
TM Welzel, B Graubard, K McGlynn · Zeitschrift für Gastroenterologie · 2009 · Heft 06
Bibliografische Angaben
Zusammenfassung
Background: The incidence of primary liver cancers hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) is increasing in the United States. Some hospital-based or experimental studies suggest that metabolic syndrome may increase the risk for HCC and ICC. In this study, we investigate the association of metabolic syndrome and primary liver cancer using data from the National Cancer Institute's Surveillance Epidemiology and End-Results Program (SEER)-Medicare linked database. Methods: All patients aged 65 years and older diagnosed with HCC and ICC between 1993 and 1999 were identified. Control…